Table 4.
Protein | Chow | C-TEN | C-TEN+NAC | Et-TEN | Et-TEN+NAC | F-Ratio | P-Value |
---|---|---|---|---|---|---|---|
IL-1β | 31.63 ± 4.321 |
85.68 ± 21.36 |
56.47 ± 6.103 |
67.16 ± 16.68 |
52.02 ± 4.738 |
10.31 | 0.036 |
IL-2 | 392.6 ± 45.03 |
929.5 ± 237 |
521.1 ± 80.05 |
976.5 ± 280.6 |
692.6 ± 48.36 |
10.77 | 0.029 |
IL-4 | 17.97 ± 2.545 |
40.19 ± 11.3 |
25.59 ± 5.391 |
36.16 ± 17.56 |
25.97 ± 3.068 |
4.25 | |
IL-6 | 229.8 ± 27.34 |
548.7 ± 176.3 |
355.4 ± 35.12 |
420.7 ± 110.2 |
434.6 ± 44.05 |
7.31 | 0.12 |
GM-CSF | 36.07a ± 7.817 |
195.1a-*** ± 36.58 |
82.28 ± 12.83 |
142.1 ± 43.76 |
83.83 ± 10.96 |
18.05 | 0.001 |
GRO/KC | 98.33a ± 7.55 |
199.9a-** ± 34.37 |
142.4 ± 14.39 |
180.7 ± 43.24 |
123.5 ± 5.058 |
12.90 | 0.012 |
TNF-α | 11.34 ± 1.898 |
14.08 ± 3.828 |
15.03 ± 2.336 |
15.82 ± 4.465 |
13.74 ± 1.865 |
3.45 | |
VEGF | 11.3 ± 1.889 |
21.5 ± 5.301 |
14.59 ± 2.562 |
27.81 ± 8.942 |
14.02 ± 0.8307 |
2.23 |
Effects of chronic ethanol and NAC treatment on pro-inflammatory cytokine and vascular endothelial growth factor (VEGF) expression in liver. Liver protein homogenates were used to measure immunoreactivity to IL-1β, IL-2, IL-4, IL-6, TNF-α, GM-CSF, GRO/KC, and VEGF by multiplex ELISA. Immunoreactivity was normalized to protein concentration and data reflect mean ± S.E.M. of fluorescence light units (arbitrary). Inter-group comparisons were made using one-way ANOVA. F-Ratios and significant P-values are indicated in the far right columns. Significant inter-group differences were detected with the post-hoc Kruskal-Wallis multiple comparison tests.
Superscript “a” indicates the comparison groups and
P<0.05;
P<0.01;
P<0.001.